Articles related to OBESITY/WEIGHT MANAGEMENT

Youth Obesity Reaches 20% in US

“These results demonstrate the uneven distribution of obesity and severe obesity across youths in the United States and underscore the need for ongoing treatment, prevention, and public health interventions.” — Dr. William J. Heerman, Vanderbilt University Medical Center

Cardiology February 25th 2026

Tags: HEALTH EQUITY HEALTHCARE DISPARITIES OBESITY/WEIGHT MANAGEMENT PREVENTIVE MEDICINE PUBLIC HEALTH

Journal of Advanced Nursing (JAN)

‘Something Was Missing’: A Qualitative Study of Parents’ Expectations in Weight-Related Health Care for Children

The societal influences, including parental weight stigma, affect how parents perceive their child’s weight and respond to health care recommendations.

Pediatric Nursing February 13th 2026

Tags: OBESITY/WEIGHT MANAGEMENT PARENT-PROVIDER COMMUNICATION PEDIATRIC ENDOCRINOLOGY PUBLIC HEALTH RESEARCH & CLINICAL TRIALS WEIGHT STIGMA

British Medical Journal (The BMJ)

Weight Regain After Cessation of Medication for Weight Management: Systematic Review and Meta-Analysis

Real world observations estimate that 50% of people with obesity discontinue GLP-1 receptor agonists within 12 months of initiation.

Cardiology February 6th 2026

Tags: GLP-1s OBESITY/WEIGHT MANAGEMENT

Healthline

FDA Approves Wegovy Weight Loss Pill: How It Compares to Injectables

“People are more used to taking pills than they are taking injections” but “90% of a person’s weight is the result of what they eat. There are no magic solutions.”

Ambulatory Care Nursing January 29th 2026

Tags: DEVICE/DRUG APPROVALS DIABETES EDUCATION FDA GLP-1s OBESITY/WEIGHT MANAGEMENT

Physician’s Weekly

ADHD, Methylphenidate, and Growth: Long-Term Outcomes in Adulthood

Mean adjusted adult BMI was significantly higher among individuals with childhood ADHD compared with controls, with the highest BMI observed in those treated with MPH for ≥365 days.

Family Medicine/General Practice January 28th 2026

Tags: ATTENTION-DEFICIT HYPERACTIVITY DISORDER (ADHD) CHILD & ADOLESCENT PSYCHIATRY HEALTH OUTCOMES OBESITY/WEIGHT MANAGEMENT PATIENT MONITORING STIMULANTS

Conexiant

FDA Drops Warning From GLP-1 RAs

The FDA concluded that GLP-1 RA medications are not associated with suicidal ideation or behavior and is requesting corresponding updates to product labeling.

Endocrinology, Diabetes, Metabolism January 27th 2026

Tags: DRUG SAFETY & INTERACTIONS FDA GLP-1s GUIDELINES/RECOMMENDATIONS OBESITY/WEIGHT MANAGEMENT

1 2 … 21 22 >>

Trending Topics:

Articles related to OBESITY/WEIGHT MANAGEMENT

Youth Obesity Reaches 20% in US

‘Something Was Missing’: A Qualitative Study of Parents’ Expectations in Weight-Related Health Care for Children

Weight Regain After Cessation of Medication for Weight Management: Systematic Review and Meta-Analysis

FDA Approves Wegovy Weight Loss Pill: How It Compares to Injectables

ADHD, Methylphenidate, and Growth: Long-Term Outcomes in Adulthood

FDA Drops Warning From GLP-1 RAs

Topics

Sources

The Healthcare Communications Network is owned and operated by IQVIA Inc. Click below to leave this site and continue to IQVIA’s Privacy Choices form

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form